Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,444	842	438	383	394	257
Market Cap Growth	86.08%	92.35%	14.25%	-2.77%	53.22%	-42.71%
Enterprise Value	1,026	471	146	147	240	184
Last Close Price	1.60	0.98	0.44	0.36	0.34	0.21
PE Ratio	12.04	6.99	4.37	4.14	4.82	4.12
PS Ratio	3.72	2.14	1.33	1.21	1.39	1.17
PB Ratio	2.62	1.45	0.88	0.82	0.98	0.82
P/TBV Ratio	2.98	1.66	1.03	1.00	1.25	1.11
P/FCF Ratio	-	6.51	4.48	3.15	4.54	2.51
P/OCF Ratio	-	5.85	4.19	2.98	3.92	2.37
EV/Sales Ratio	2.61	1.20	0.44	0.46	0.85	0.84
EV/EBITDA Ratio	7.62	3.45	1.27	1.38	2.38	2.37
EV/EBIT Ratio	7.97	3.65	1.38	1.51	2.63	2.67
EV/FCF Ratio	-	3.64	1.49	1.21	2.77	1.79
Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.21	0.22
Debt / EBITDA Ratio	0.23	0.26	0.57	0.58	0.83	0.88
Debt / FCF Ratio	-	0.27	0.67	0.51	0.97	0.67
Asset Turnover	0.56	0.52	0.50	0.51	0.49	0.46
Inventory Turnover	2.35	2.07	1.99	2.12	2.13	1.97
Quick Ratio	3.29	3.09	2.60	2.47	2.06	1.80
Current Ratio	3.54	3.32	2.86	2.68	2.25	2.00
Return on Equity (ROE)	23.60%	22.07%	21.38%	21.53%	21.64%	19.98%
Return on Assets (ROA)	11.58%	10.73%	9.93%	9.66%	9.93%	8.98%
Return on Capital (ROIC)	14.26%	13.41%	12.39%	12.05%	12.53%	11.60%
Return on Capital Employed (ROCE)	22.60%	21.80%	20.60%	20.20%	22.00%	21.00%
Earnings Yield	8.30%	14.31%	22.87%	24.18%	20.73%	24.28%
FCF Yield	-	15.37%	22.34%	31.73%	22.03%	39.84%
Dividend Yield	4.88%	7.60%	11.75%	10.07%	9.85%	14.27%
Payout Ratio	-	74.75%	41.59%	18.67%	33.56%	26.36%
Buyback Yield / Dilution	-6.04%	-4.12%	-0.91%	1.58%	1.54%	4.35%
Total Shareholder Return	-1.17%	3.48%	10.85%	11.65%	11.39%	18.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.